Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01059942 · ClinicalTrials.gov registry record
Development and Validation of a Tool to Measure Hand-off Quality
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 27
- Enrollment target
NCT01059942: Completed study, sponsored by University of Chicago.
NCT01059942 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01059942 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The aim of this project is to develop and validate a simple, flexible, reliable, real-time observation tool to evaluate hand-off practices. The Hand-off CEX is a paper-based instrument that can be used to evaluate either the sender or the receiver of hand-off communication. This tool is based on a previously-validated, widely-used, real-time educational evaluation tool (the Mini-CEX); published expert opinion; and our prior research . The investigators' tool incorporates unique role-based anchors for both senders and receivers that refer to verbal communication, professionalism and environment, hand-off domains informed by preliminary work and expert opinion. The Hand-off CEX(Clinical Evaluation Exercise) will be used by academic hospitalists and house-staff physicians to assess feasibility. We, the investigators, will also assess the construct validity and inter-rater reliability of the tool through the use of standardized, videotaped hand-off scenarios depicting various levels of performance of a hand-off scenario. We hypothesize that the Hand-off CEX will arm educators with an innovative, necessary, valid and feasible method for training health professionals to conduct safe and effective hand-offs. Finally, the Hand-off CEX will be a useful tool to assist hospitals in improving patient safety.
Interventions
- OTHER mock handoff exposure
- OTHER Introduction of CEX tool in Actual Hand-offs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-12 |
What the finished NCT01059942 record still lists
NCT01059942 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which mock handoff exposure is the first listed.
NCT01059942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01059942 about?
NCT01059942 is a clinical study titled "Development and Validation of a Tool to Measure Hand-off Quality". The aim of this project is to develop and validate a simple, flexible, reliable, real-time observation tool to evaluate hand-off practices. The Hand-off CEX is a paper-based instrument that can be used to evaluate either the sender or the receiver of hand-off communication. This tool is based on a p...
What is the current status of trial NCT01059942?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2010-01. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01059942?
The interventions under investigation include: mock handoff exposure (OTHER), Introduction of CEX tool in Actual Hand-offs (OTHER).
Who is sponsoring clinical trial NCT01059942?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia